Site-specific physical targeting via external magnetic field

"Site-specific physical targeting via external magnetic field" does **not** refer to a specific molecule, receptor, or canonical therapeutic target. Instead, it describes a **physical method** for concentrating therapeutics—typically drugs bound to or encapsulated within magnetically responsive nanoparticles—at a desired anatomical location by applying an external magnetic field. This approach is most commonly explored in cancer therapy and regenerative medicine to increase local drug concentrations while minimizing systemic exposure and side effects[1][2][4]. The technique relies on the use of materials such as iron oxide nanoparticles that can be manipulated by magnets after administration. While promising for non-invasive and precise delivery, challenges include limited depth penetration with static fields, potential toxicity from carrier materials, rapid clearance from circulation by immune cells, and technical limitations in controlling the spatial focus of the applied fields[1][2][4].\n\nThis entry should be flagged as incorrect for molecular/receptor databases because it does not represent a discrete biological entity but rather an engineering strategy or modality.

Other names

Magnetic drug targetingMagnetically guided drug deliveryMagnetogenetic targeting (context-dependent)

Physical concentration of drug-loaded magnetic carriers at a target site using an external magnetic field[2][4][6]